Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspective
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Several studies have provided ample evidence of a clinically significant interobserver variation of the histological diagnosis of glioma. This interobserver variation has an effect on both the typing and grading of glial tumors. Since treatment decisions are based on histological diagnosis and grading, this affects patient care: erroneous classification and grading may result in both over- and undertreatment. In particular, the radiotherapy dosage and the use of chemotherapy are affected by tumor grade and lineage. It also affects the conduct and interpretation of clinical trials on glioma, in particular of studies into grade II and grade III gliomas. Although trials with central pathology review prior to inclusion will result in a more homogeneous patient population, the interpretation and external validity of such trials are still affected by this, and the question whether results of such trials can be generalized to patients diagnosed and treated elsewhere remains to be answered. Although molecular classification may help in typing and grading tumors, as of today this is still in its infancy and unlikely to completely replace histological classification. Routine pathology review in everyday clinical practice should be considered. More objective histological criteria for the grade and lineage of gliomas are urgently needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Histologic diagnosis and grading of gliomas have been limited by considerable intra- and interobserver variability (42).”
From Predicting cancer outcomes from histology and genomics using convolutional networks (2018) · cites this paper as [42]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, the grading criteria in the current classification schema for oligodendrogliomas continues to predominantly rely upon histopathologic examination; the differentiating criterion between grade 2 and grade 3 oligodendrogliomas are the presence of conspicuous microvascular proliferation and/or 6 mitoses per 10 high-power field [3,4,5,6,7,8,9,10,11].”
From BPC 157 Therapy of Myotendinous Junction Injury in Rats (2025) · cites this paper as [9]
Experimental — accuracy not yet measuredIn the citing paper
“Importantly, these data further facilitate consensus ratings on radiology images (e.g., MRI) of expert radiologists to alleviate inconsistencies that often arise due to subjective impressions and inter- and intra-observer variability [229].”
From AI in Medical Imaging Informatics: Current Challenges and Future Directions (2020) · cites this paper as [229]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
Rothwell, P. M. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17670-8 · Cited by 2,544 · cited 1×
“This issue is on the question of external validation or generalizability of the results of a trial, an often ignored element of clinical trials [26].”
BackgroundCairncross, J. G., Ueki, K., Zlatescu, M. C., Lisle, D. K., Finkelstein, D. M., Hammond, R. R., Silver, J. S., Stark, P. C., Macdonald, D. R., Ino, Y., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.19.1473 · Cited by 1,610
Feinstein, A. R., Sosin, D. M., & Wells, C. K. (1985) · New England Journal of Medicine · doi:10.1056/nejm198506203122504 · Cited by 1,544
An analysis of 8305 cases of carcinoid tumors
Modlin, I. M., & Sandor, A. (2000) · Cancer · doi:10.1002/(sici)1097-0142(19970215)79:4<813::aid-cncr19>3.0.co;2-2 · Cited by 1,200
Nutt, C. L., Mani, D. R., Betensky, R. A., Tamayo, P., Cairncross, J. G., Ladd, C., Pohl, U., Hartmann, C. J., McLaughlin, M. E., Batchelor, T. T., et al. (2003) · PubMed · Cited by 1,058
van den Bent, M., Afra, D., de Witte, O., Hassel, M. B., Schraub, S., Hoang-Xuan, K., Malmström, P.-O., Collette, L., Piérart, M., Mirimanoff, R., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67070-5 · Cited by 1,035
Wick, W., Hartmann, C., Engel, C., Stoffels, M., Felsberg, J., Stockhammer, F., Sabel, M. C., Koeppen, S., Ketter, R., Meyermann, R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.6497 · Cited by 809
Smith, J. S., Perry, A., Borell, T. J., Lee, H. K., O’Fallon, J., Hosek, S. M., Kimmel, D., Yates, A., Burger, P. C., Scheithauer, B. W., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.3.636 · Cited by 804
van den Bent, M. J., Carpentier, A. F., Brandes, A. A., Sanson, M., Taphoorn, M. J. B., Bernsen, H. J. J. A., Frenay, M., Tijssen, C. C., Grisold, W., Sipos, L., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.6078 · Cited by 748
Research works printed but not linked: 1
- Coons SW, Johnson PC, Scheithauer BW, Yates AJ, Pearl DK (1997) Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 79:1381–1391 · doi:10.1002/(sici)1097-0142(19970401)79:7<1381::aid-cncr16>3.0.co;2-w
Cited by
Items 301–400 of 640
RTOG 9802: Good Wines Need Aging
van den Bent, M. J., Jaeckle, K. A., Baumert, B. G., & Wick, W. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.6896 · Cited by 15
Hu, P., Xu, L., Qi, Y., Yan, T., Ye, L., Wen, S., Yuan, D., Zhu, X., Deng, S., Liu, X., et al. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1183032 · Cited by 14
IGF2BP2 modulates autophagy and serves as a prognostic marker in glioma
Li, N., Deng, L., Zhang, Y., Tang, X., Lei, B., & Zhang, Q. (2024) · Ibrain · doi:10.1002/ibra.12150 · Cited by 14
Zhang, X., Zhang, X., Liu, T., & Sha, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-68784-y · Cited by 14
Molecular biomarkers and integrated pathological diagnosis in the reclassification of gliomas
Ruiz, F., Gennaro, M., Bastone, L., Godoy, A., Torruella, M., & Pérez, G. (2021) · Molecular and Clinical Oncology · doi:10.3892/mco.2021.2312 · Cited by 14
Inter‐pathologist agreement on diagnosis, classification and grading of canine glioma
Krane, G. A., Shockley, K. R., Malarkey, D. E., Miller, A. D., Miller, C. R., Tokarz, D. A., Jensen, H. L., Janardhan, K. S., Breen, M., & Mariani, C. L. (2022) · Veterinary and Comparative Oncology · doi:10.1111/vco.12853 · Cited by 14
Tran, P. M. H., Tran, L. K. H., Nechtman, J., dos Santos, B., Purohit, S. B., Satter, K. B., Dun, B., Kolhe, R. B., Sharma, S., Bollag, R. J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-77777-6 · Cited by 14
Brorsen, L. F., McKenzie, J. S., Tullin, M. F., Bendtsen, K. M., Pinto, F. E., Jensen, H. E., Hædersdal, M., Takáts, Z., Janfelt, C., & Lerche, C. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-62023-0 · Cited by 13
Nanopore-based random genomic sampling for intraoperative molecular diagnosis
Emiliani, F. E., Ismail, A. A. O., Hughes, E. G., Tsongalis, G. J., Zanazzi, G. J., & Lin, C. (2025) · Genome Medicine · doi:10.1186/s13073-025-01427-7 · Cited by 13
Molecular characteristics of diffuse lower grade gliomas: what neurosurgeons need to know
Young, J. S., Gogos, A., Morshed, R. A., Hervey‐Jumper, S. L., & Berger, M. S. (2020) · Acta Neurochirurgica · doi:10.1007/s00701-020-04426-2 · Cited by 14
ZEB1 Is a Transcription Factor That Is Prognostic and Predictive in Diffuse Gliomas
Edwards, L., Kim, S., Madany, M., Nuño, M., Thomas, T., Li, A., Berel, D., Lee, B.-S., Liu, M., Black, K. L., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2018.01199 · Cited by 13
Zhu, P., Zhang, C., Yang, P., Chen, J., Liu, Y., Hu, H., Huang, H., Bao, Z., Zhang, W., Kong, W., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7154 · Cited by 13
Broggi, G., Mazzucchelli, M., Salzano, S., Barbagallo, G. M. V., Certo, F., Zanelli, M., Palicelli, A., Zizzo, M., Koufopoulos, N. I., Magro, G. G., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155671 · Cited by 12
Multi-omics analysis identifies novels genes involved in glioma prognosis
Li, Y., & Sun, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-90658-0 · Cited by 12
Li, D., Chen, Y., Wong, T.-F., Yang, Q., Guo, C., Jiang, X., Ke, C., Zhang, X., Zeng, J., Lv, Y., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-95693-5 · Cited by 12
DeepBLS: Deep Feature-Based Broad Learning System for Tissue Phenotyping in Colorectal Cancer WSIs
Bakht, A. B., Javed, S., Gilani, S. Q., Karki, H., Muneeb, M., & Werghi, N. (2023) · Journal of Imaging Informatics in Medicine · doi:10.1007/s10278-023-00797-x · Cited by 12
Ma, Y., Shi, F., Sun, T., Chen, H., Cheng, H., Liu, X., Wu, S., Lu, J., Zou, Y., Zhang, J., et al. (2023) · Journal of Neuro-Oncology · doi:10.1007/s11060-023-04306-6 · Cited by 12
Ozono, I., Onishi, S., Yonezawa, U., Taguchi, A., Khairunnisa, N. I., Amatya, V. J., Yamasaki, F., Takeshima, Y., & Horie, N. (2024) · Journal of Neuro-Oncology · doi:10.1007/s11060-024-04758-4 · Cited by 12
CLINICAL RELEVANCE OF MOLECULAR MARKERS IN GLIOMAS
Monga, V., Jones, K. A., & Chang, S. M. (2017) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2017.05.003 · Cited by 12
A new glioma grading model based on histopathology and Bone Morphogenetic Protein 2 mRNA expression
Zhou, K., Zhao, Z., Li, S., Liu, Y., Li, G., & Jiang, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-75574-9 · Cited by 12
Impact of new molecular criteria on diagnosis and survival of adult glioma patients
Mortensen, D., Ulhøi, B. P., Lukacova, S., Alsner, J., Stougaard, M., & Nyengaard, J. R. (2022) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2022.09.005 · Cited by 12
Wang, W., Tugaoen, J. D. C., Fadda, P., Toland, A. E., Ma, Q., Elder, J. B., Giglio, P., Giglio, P., Ong, S., Pillainayagam, C. P., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01587-w · Cited by 12
Inter- and Intraobserver Agreement of Canine and Feline Nervous System Tumors
Belluco, S., Avallone, G., Palma, S. D., Rasotto, R., & Oevermann, A. (2019) · Veterinary Pathology · doi:10.1177/0300985818824952 · Cited by 12
Verburg, N., Koopman, T., Yaqub, M. M., Hoekstra, O. S., Lammertsma, A. A., Schwarte, L. A., Barkhof, F., Pouwels, P. J. W., Heimans, J. J., Reijneveld, J. C., et al. (2019) · EJNMMI Research · doi:10.1186/s13550-019-0523-8 · Cited by 12
Mair, M. J., Werner, J., Weller, J., Barci, E., Katzendobler, S., Isakaj, J., Berchtold, L., Aras, T., Stürzl, R., Hennenberg, J., et al. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf196 · Cited by 11
Lung Cancer Computational Biology and Resources
Cai, L., Xiao, G., Gerber, D. E., Minna, J. D., & Xie, Y. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a038273 · Cited by 11
Hendriks, T., Birmpili, A., Vleeschouwer, S. D., Heeren, R. M. A., & Cuypers, E. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00463 · Cited by 11
Evolving Insights into the Molecular Neuropathology of Diffuse Gliomas in Adults
Barthel, F. P., Johnson, K. C., Wesseling, P., & Verhaak, R. G. W. (2018) · Neurologic Clinics · doi:10.1016/j.ncl.2018.04.002 · Cited by 11
The role of surgery in grade II/III oligodendroglial tumors
Thon, N., Kreth, F.-W., & Tonn, J. (2015) · CNS Oncology · doi:10.2217/cns.15.26 · Cited by 11
Génétique et gliomes cérébraux
Alentorn, A., Labussière, M., Sanson, M., Delattre, J., Hoang‐Xuan, K., & Idbaïh, A. (2012) · La Presse Médicale · doi:10.1016/j.lpm.2012.05.013 · Cited by 11
Gupta, T., Nair, V. J., Epari, S., Pietsch, T., & Jalali, R. (2012) · Neurology India · doi:10.4103/0028-3886.93594 · Cited by 11
Shih, C., Ekoma, S., Ho, C., Pradhan, K. R., Hwang, E., Jakacki, R. I., Fisher, M., Kilburn, L., Horn, M., Vézina, G., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos092 · Cited by 11
Clinical importance of molecular markers of adult diffuse glioma
Molinari, E., Curran, O. E., & Grant, R. (2019) · Practical Neurology · doi:10.1136/practneurol-2018-002116 · Cited by 11
AI-Powered Histology for Molecular Profiling in Brain Tumors: Toward Smart Diagnostics from Tissue
Sakaguchi, M., Yoshizawa, A., Masui, K., Sakai, T., & Komori, T. (2025) · Cancers · doi:10.3390/cancers18010009 · Cited by 10
Mu, N., Yang, C., Ma, K., Quan, Y., Wang, S., Lai, Y., Li, F., Wang, Y., Chen, T., Xu, D., et al. (2022) · Acta Physica Sinica · doi:10.7498/aps.71.20212419 · Cited by 10
Thirty years of progress in the management of low-grade gliomas
van den Bent, M. J. (2023) · Revue Neurologique · doi:10.1016/j.neurol.2023.03.001 · Cited by 10
Lu, Y., Du, N., Fang, X., Shu, W., Liu, W., Xu, X., Yao, Y., Li, X., Mao, R., Li, K., et al. (2024) · Cancer Imaging · doi:10.1186/s40644-024-00726-3 · Cited by 10
Xiong, D., He, R., Huang, Z., Wu, K.-J., Mo, Y.-Y., Liang, Y., Yang, D., Wu, Y., Tang, Z.-Q., Liao, Z.-T., et al. (2024) · Digital Health · doi:10.1177/20552076241277735 · Cited by 10
Kim, Y. Z., Kim, C., Lim, J., Sung, K. S., Lee, J., Oh, H.-J., Kang, S., Kang, S.-H., Kong, D., Kim, S. H., et al. (2019) · Brain Tumor Research and Treatment · doi:10.14791/btrt.2019.7.e42 · Cited by 10
Is chemotherapy alone an option as initial treatment for low-grade oligodendrogliomas?
Rudà, R., Touat, M., & Soffietti, R. (2020) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000866 · Cited by 10
Liu, J., Yang, X., Ji, Q., Yang, L., Li, J., Long, X., Ye, M., Huang, K., & Zhu, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.875131 · Cited by 10
Noninvasive Classification of Glioma Subtypes Using Multiparametric MRI to Improve Deep Learning
Xiong, D., Ren, X., Huang, W., Wang, R., Ma, L., Gan, T., Ai, K., Wen, T., Li, Y., Wang, P., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12123063 · Cited by 10
Preusser, M., Geurts, M., Hainfellner, J. A., & van den Bent, M. J. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad113 · Cited by 10
Nagahisa, S., Watabe, T., Sasaki, H., Nishiyama, Y., Hayashi, T., Hasegawa, M., & Hirose, Y. (2013) · Neurosurgical Review · doi:10.1007/s10143-013-0467-9 · Cited by 10
Kim, Y. Z., Kim, C., Wee, C. W., Roh, T. H., Hong, J. B., Oh, H.-J., Kang, S., Kang, S.-H., Kong, D., Kim, S. H., et al. (2019) · Brain Tumor Research and Treatment · doi:10.14791/btrt.2019.7.e43 · Cited by 10
Explainable Machine Learning Models for Glioma Subtype Classification and Survival Prediction
Vershinina, O., Turubanova, V. D., Krivonosov, M., Trukhanov, A. I., & Ivanchenko, M. (2025) · Cancers · doi:10.3390/cancers17162614 · Cited by 9
Lung Cancer Detection from Histopathological Images Using Deep Learning
Mohalder, R. D., Hossain, K. A., Sarkar, J. P., Paul, L., Raihan, M., & Talukder, K. H. (2023) · Lecture notes of the Institute for Computer Sciences, Social Informatics and Telecommunications Engineering · doi:10.1007/978-3-031-34619-4_17 · Cited by 9
Lee, D. Y., Choi, K. E., Han, K., Choi, S. H., Lee, N., Ahn, S. S., Chang, J. H., Kim, S. H., Lee, S., & Park, Y. W. (2024) · Neuroradiology · doi:10.1007/s00234-024-03430-y · Cited by 9
Educational Case: Histologic and Molecular Features of Diffuse Gliomas
Zhang, S., & William, C. M. (2020) · Academic Pathology · doi:10.1177/2374289520914021 · Cited by 9
Hu, L., Brat, D. J., Bloch, O. G., Ramkissoon, S. H., & Lesser, G. J. (2020) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_280955 · Cited by 9
Pediatric Pan-Central Nervous System Tumor Methylome Analyses Reveal Immune-Related LncRNAs
Li, Y., Xu, S., Xu, D., Pan, T., Guo, J., Gu, S., Lin, Q., Li, X., Li, K., & Xiang, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.853904 · Cited by 9
Wu, Y., Mao, M., & Wang, L.-J. (2023) · Aging · doi:10.18632/aging.205018 · Cited by 9
Les tumeurs gliales diffuses de l’adulte: Hétérogénéité génétique et implications thérapeutiques
Verreault, M., Delattre, J., & Idbaïh, A. (2012) · médecine/sciences · doi:10.1051/medsci/20122810005 · Cited by 9
Reappraising the 2016 WHO classification for diffuse glioma
Lin, A. L., & DeAngelis, L. M. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox003 · Cited by 9
Long-read sequencing for brain tumors
Shelton, W. J., Zandpazandi, S., Nix, J. S., Gökden, M., Bauer, M., Ryan, K. R., Wardell, C. P., Vaske, O. M., & Rodriguez, A. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1395985 · Cited by 8
Pathomics models for CD40LG expression and prognosis prediction in glioblastoma
Li, W., Xiao, J., Zhang, C., Di, X., Yao, J., Li, X., Huang, J., & Li, Z. (2024) · Scientific Reports · doi:10.1038/s41598-024-75018-8 · Cited by 8
Zhou, Z., Xu, J., Huang, N., Tang, J., Ma, P., & Cheng, Y. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s353762 · Cited by 8
Multiclass tumor identification using combined texture and statistical features
Latif, G., Bashar, A., Iskandar, D. N. F. A., Mohammad, N., Brahim, G. B., & Alghazo, J. M. (2022) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-022-02687-w · Cited by 8
Jin, L., Sun, T., Liu, X., Cao, Z., Liu, Y., Chen, H., Ma, Y., Zhang, J., Zou, Y., Liu, Y., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108041 · Cited by 8
Anaplastic astrocytomas: survival and prognostic factors in a surgical series
Rogne, S. G., Konglund, A. E., Scheie, D., Helseth, E., & Meling, T. R. (2014) · Acta Neurochirurgica · doi:10.1007/s00701-014-2053-5 · Cited by 8
« OMICS » et biomarqueurs dans les tumeurs gliales
Idbaïh, A. (2011) · Revue Neurologique · doi:10.1016/j.neurol.2011.07.007 · Cited by 8
Arakawa, Y., Saito, R., Kanemura, Y., Mishima, K., Koriyama, S., Narita, Y., Kumabe, T., Motomura, K., Sugiyama, K., Yamasaki, F., et al. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf258 · Cited by 7
Chirica, M., Jurmeister, P. S., Teichmann, D., Koch, A., Pérez, E., Schmid, S., Simon, M., Driever, P. H., Bodden, C., van Tilburg, C. M., et al. (2024) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.13010 · Cited by 7
SNUH methylation classifier for CNS tumors
Lee, K.-H., Jeon, J., Park, J. W., Yu, S., Won, J., Kim, K., Park, C., & Park, S. (2025) · Clinical Epigenetics · doi:10.1186/s13148-025-01824-0 · Cited by 7
Incorporating Targeted Therapy Into Neuro-Oncology Practice
Geurts, M., Blaquier, J. B., Wijnenga, M. M. J., Kamson, D. O., & de la Fuente, M. I. (2025) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk-25-473324 · Cited by 7
Rapid diagnosis of adult-type diffuse glioma using a layered scheme
Wu, J., Wu, S., Cao, D., Xiong, Z., Zhang, J., Zou, Y., Wu, Z., Nie, Y., Luo, C., Yao, Y., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04124-9 · Cited by 7
A Radiosensitivity Gene Signature and XPO1 Predict Clinical Outcomes for Glioma Patients
Wu, S., Qiao, Q., & Li, G. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00871 · Cited by 7
Dissecting and analyzing the Subclonal Mutations Associated with Poor Prognosis in Diffuse Glioma
Bai, M., Wang, X., Zhang, H., Wang, J., Lyaysan, G., Xu, S., Tian, K., Wang, T., Li, J., Wang, N., et al. (2022) · BioMed Research International · doi:10.1155/2022/4919111 · Cited by 7
Advances in Central Nervous System Tumor Classification
Malta, T. M., Snyder, J., Noushmehr, H., & Castro, A. V. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-29750-2_10 · Cited by 7
Belluco, S., Marano, G., Lurier, T., Avallone, G., Brachelente, C., Palma, S. D., Rasotto, R., Baiker, K., Beineke, A., Oevermann, A., et al. (2023) · Veterinary and Comparative Oncology · doi:10.1111/vco.12932 · Cited by 7
Clinical impact of molecular profiling in rare brain tumors
Pratt, D. W., Peñas-Prado, M., & Gilbert, M. R. (2023) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001211 · Cited by 7
Satomi, K., Ichimura, K., & Shibahara, J. (2024) · Pathology International · doi:10.1111/pin.13402 · Cited by 7
Qiao, B., Jumai, K., Ainiwaer, J., Niyaz, M., Zhang, Y., Ma, Y., Zhang, L., Luh, W., & Sheyhidin, I. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11981 · Cited by 7
Luo, S., Zhu, S., Liao, J., Zhang, Y., Hou, X., Luo, T., Zhao, E., Xu, J., Pang, L., Liang, X., et al. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12671 · Cited by 7
Rodrigues, A. J., Jin, M. C., Wu, A., Bhambhvani, H. P., Li, G., & Grant, G. A. (2021) · Journal of Neurosurgery Pediatrics · doi:10.3171/2021.1.peds20859 · Cited by 7
Anaplastic oligodendroglial tumors
van den Bent, M. J., & Bromberg, J. E. C. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53502-3.00003-3 · Cited by 7
Sippl, C., Stark, F., Schneider, K. I., Medina, B. R., Schulz‐Schaeffer, W., Brinkmann, M., Neumann, F., Droop, R., Ullmann, S., Würthwein, T., et al. (2026) · Cancers · doi:10.3390/cancers18071053 · Cited by 6
Han, J., Jing, Y., & Sun, P. (2023) · Journal of Healthcare Engineering · doi:10.1155/2023/6603151 · Cited by 6
Coletti, R., de Mendonça, M. L., Vinga, S., & Lopes, M. B. (2024) · Bioinformatics and Biology Insights · doi:10.1177/11779322241271535 · Cited by 6
Halani, S. H., & Brat, D. J. (2015) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1074333 · Cited by 6
The emerging applications and advancements of Raman spectroscopy in pediatric cancers
Li, C., Feng, C., Xu, R., Jiang, B., Li, L., He, Y., Tu, C., & Li, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1044177 · Cited by 6
Schepke, E., Löfgren, M., Pietsch, T., Kling, T., Nordborg, C., Bontell, T. O., Holm, S., Öberg, A., Nyman, P. O., Eliasson‐Hofvander, M., et al. (2023) · Clinical Epigenetics · doi:10.1186/s13148-023-01456-2 · Cited by 6
Yang, J., Shen, L., Zhou, J., Wu, J., Yue, C., Wang, T., Chai, S., Cai, Y., Xu, D., Lei, Y., et al. (2024) · Biochemical Genetics · doi:10.1007/s10528-024-10928-w · Cited by 6
Koo, T., Lim, D. H., Seol, H. J., Dho, Y., Kim, I. H., Chang, J. H., Lee, J., Jung, T., Gwak, H., Cho, K. H., et al. (2018) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-2972-8 · Cited by 6
Zhu, Q., Liang, Y., Fan, Z., Liu, Y., Zhou, C., Zhang, H., He, L., Li, T., Yang, J., Zhou, Y., et al. (2022) · Neurosurgical FOCUS · doi:10.3171/2022.1.focus21596 · Cited by 6
Peng, H., Wang, Y., Wang, P., Huang, C., Liu, Z., & Wu, C. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.919391 · Cited by 6
Vorasidenib in IDH mutant WHO grade 2 gliomas: time to stop sitting on the fence?
Dipasquale, A., Franceschi, E., Lombardi, G., & Simonelli, M. (2024) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdae003 · Cited by 5
Nardini, D., Toaha, A., Bonaudo, C., Ezhov, I., Artemiou, A., Camelia, M., Nozzoli, F., Giannoni, L., Tachtsidis, I., Puppa, A. D., et al. (2025) · Journal of Biomedical Optics · doi:10.1117/1.jbo.30.12.126007 · Cited by 5
Current and emerging therapies in IDH-mutant glioma
Nakhate, V., Youssef, G., & Wen, P. Y. (2026) · Neurotherapeutics · doi:10.1016/j.neurot.2026.e00913 · Cited by 5
Standardizing analysis of intra‐tumoral heterogeneity with computational pathology
Paliwal, A., Faust, K., Alshoumer, A., & Diamandis, P. (2023) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23146 · Cited by 5
Latysheva, A., Emblem, K. E., Server, A., Brandal, P., Meling, T. R., Pahnke, J., & Hald, J. K. (2018) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0000000000000742 · Cited by 5
Buvarp, D., Rydén, I., Sunnerhagen, K. S., Bontell, T. O., Vecchio, T. G., Smits, A., & Jakola, A. S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040645 · Cited by 5
Lu, J., Liang, K., Zou, R., Peng, Y., Wang, H., Huang, R., Zeng, Z., Feng, Z., Fan, Y., Zhang, S., et al. (2023) · Aging · doi:10.18632/aging.204841 · Cited by 5
Rajagopal, R., Teng, A. J., Jawin, V., Wong, O. L., Mahsin, H., Rani, N. H. A., Yap, T. Y., Gunasagaran, K., Thevarajah, A., Yeoh, S. L., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1278611 · Cited by 5
Fu, Q.-Y., Xiong, X., Xia, H.-F., Liu, X.-C., Yu, Z., Liu, K., Zeng, J., Sun, Y., Jia, J., & Chen, G. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216897 · Cited by 5
Sadraoui, A., Martin, S., Barbot, E., Laurent-Bellue, A., Pesquet, J.-C., Guettier, C., & Ayed, I. B. (2024) · IEEE International Symposium on Biomedical Imaging (ISBI) · doi:10.1109/isbi56570.2024.10635817 · Cited by 5
Animal Models in Glioblastoma: Use in Biology and Developing Therapeutic Strategies
Schuhmacher, A. J., & Squatrito, M. (2017) · Current cancer research · doi:10.1007/978-3-319-56820-1_9 · Cited by 5
Liu, Q., Wang, K., Huang, R., Tong, X., Jiang, T., Wang, J., & Yang, P. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03132-x · Cited by 5
Tran, P. M. H., Tran, L. K. H., Satter, K. B., Purohit, S. B., Nechtman, J., Hopkins, D., dos Santos, B., Bollag, R. J., Kolhe, R. B., Sharma, S., et al. (2021) · Cancers · doi:10.3390/cancers13030439 · Cited by 5
Karabacak, M., Ozkara, B. B., Senparlak, K., & Bisdas, S. (2023) · Applied Sciences · doi:10.3390/app13063873 · Cited by 5
Metadata
- Authors
- van den Bent, M. J.
- Venue
- Acta Neuropathologica
- Published
- 2010-07-20
- Volume
- 120
- Issue
- 3
- Pages
- 297-304
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC2910894
- OpenAlex
- W2112567075
- Cited by
- 577
- References
- 35
- Citations by year
- 2026: 19 · 2025: 36 · 2024: 70 · 2023: 43 · 2022: 43 · 2021: 47 · 2020: 48 · 2019: 52 · 2018: 33 · 2017: 46 · 2016: 44 · 2015: 33 · 2014: 16 · 2013: 16 · 2012: 20
- FWCI
- 6.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Acta Neuropathologica (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Reliability and Agreement in Measurement
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
- Keywords
- glioma, interobserver variability, histopathological diagnosis, tumor grading, tumor classification, central pathology review, clinical trial interpretation, generalizability, molecular classification, chemotherapy
- MeSH terms
- Brain Neoplasms, Clinical Trials as Topic, Glioma, Humans, Observer Variation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.